625P Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update.
Saved in:
| Title: | 625P Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update. |
|---|---|
| Authors: | Mourey, L.1 (AUTHOR), Conter, H.J.2 (AUTHOR), Shore, N.3 (AUTHOR), Berry, W.R.4 (AUTHOR), Fong, P.C.5 (AUTHOR), Piulats, J.M.6 (AUTHOR), Appleman, L.J.7 (AUTHOR), Todenhöfer, T.8 (AUTHOR), Gravis, G.9 (AUTHOR), Laguerre, B.10 (AUTHOR), Gurney, H.11 (AUTHOR), Retz, M.12 (AUTHOR), Romano, E.13 (AUTHOR), de Bono, J.S.14 (AUTHOR), Kam, A.E.15 (AUTHOR), Emmenegger, U.16 (AUTHOR), Wu, H.17 (AUTHOR), Qiu, P.17 (AUTHOR), Schloss, C.17 (AUTHOR), Yu, E.Y.18 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS516-S517. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695419 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 625P Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mourey%2C+L%2E%22">Mourey, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Conter%2C+H%2EJ%2E%22">Conter, H.J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shore%2C+N%2E%22">Shore, N.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berry%2C+W%2ER%2E%22">Berry, W.R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fong%2C+P%2EC%2E%22">Fong, P.C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Piulats%2C+J%2EM%2E%22">Piulats, J.M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Appleman%2C+L%2EJ%2E%22">Appleman, L.J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Todenhöfer%2C+T%2E%22">Todenhöfer, T.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gravis%2C+G%2E%22">Gravis, G.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laguerre%2C+B%2E%22">Laguerre, B.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gurney%2C+H%2E%22">Gurney, H.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Retz%2C+M%2E%22">Retz, M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Romano%2C+E%2E%22">Romano, E.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Bono%2C+J%2ES%2E%22">de Bono, J.S.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kam%2C+A%2EE%2E%22">Kam, A.E.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Emmenegger%2C+U%2E%22">Emmenegger, U.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+H%2E%22">Wu, H.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiu%2C+P%2E%22">Qiu, P.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schloss%2C+C%2E%22">Schloss, C.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+E%2EY%2E%22">Yu, E.Y.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS516-S517. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695419 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.884 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S516 Titles: – TitleFull: 625P Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mourey, L. – PersonEntity: Name: NameFull: Conter, H.J. – PersonEntity: Name: NameFull: Shore, N. – PersonEntity: Name: NameFull: Berry, W.R. – PersonEntity: Name: NameFull: Fong, P.C. – PersonEntity: Name: NameFull: Piulats, J.M. – PersonEntity: Name: NameFull: Appleman, L.J. – PersonEntity: Name: NameFull: Todenhöfer, T. – PersonEntity: Name: NameFull: Gravis, G. – PersonEntity: Name: NameFull: Laguerre, B. – PersonEntity: Name: NameFull: Gurney, H. – PersonEntity: Name: NameFull: Retz, M. – PersonEntity: Name: NameFull: Romano, E. – PersonEntity: Name: NameFull: de Bono, J.S. – PersonEntity: Name: NameFull: Kam, A.E. – PersonEntity: Name: NameFull: Emmenegger, U. – PersonEntity: Name: NameFull: Wu, H. – PersonEntity: Name: NameFull: Qiu, P. – PersonEntity: Name: NameFull: Schloss, C. – PersonEntity: Name: NameFull: Yu, E.Y. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |